US SEC Filings Daily Market Digest — April 28, 2026

28-04-2026

KB Financial Group Inc. filed its Form 20-F Annual Report on April 28, 2026, providing a table of contents covering financial information, market risks, controls, and additional disclosures. The report highlights restrictions on subsidiary dividends under the Korean Commercial Code and Bank Act, including a requirement to allocate at least 10% of net profit to a legal reserve until it equals paid-in capital, and potential Financial Services Commission restrictions if capital adequacy ratios are not met. Other disclosures include merchant fees charged to members ranging from 0.4% to 2.3% with discounts for small- and medium-sized enterprises, and exclusions of proceeds from non-performing loan sales.

• ·Dividends payable only from distributable income calculated as net assets minus paid-in capital, mandatory legal reserves, and certain unrealized profits as of prior fiscal period end.
• ·Financial Services Commission may restrict bank dividends if capital adequacy ratio not met or under management improvement measures.
• ·Merchant fees include maintenance, prepayment costs, processing, delinquency management, loan loss provisions, and fixed costs.
• ·Excludes proceeds from sales of non-performing loans that were written off.

28-04-2026

28-04-2026

Armstrong World Industries reported first-quarter 2026 net sales of $409.9 million, up 7.1% YoY from $382.7 million, with Mineral Fiber sales increasing 4.9% to $257.2 million and Architectural Specialties surging 11.0% to $152.7 million. However, operating income fell 4.4% to $94.2 million from $98.5 million, driven by non-recurring costs including tariff adjustments and acquisition expenses, while Architectural Specialties operating income declined sharply 37.2% to $9.3 million. Adjusted EBITDA rose slightly 0.8% to $130 million, and the company reaffirmed 2026 guidance for net sales (8-10% growth) and Adjusted EBITDA (8-12% growth) while raising Adjusted Diluted EPS guidance to 10-14% growth.

• ·Cash flows from operating activities decreased $9 million YoY in Q1 2026.
• ·Cash used for investing activities increased $57 million YoY, primarily due to Eventscape acquisition.
• ·Repurchased 0.3 million shares at average $176.00 per share; $473 million remaining under authorization.
• ·2026 Adjusted EBITDA guidance: $600M to $620M (8% to 12% growth vs. 2025 $555M).
• ·Total assets as of March 31, 2026: $1,985.9 million (up from $1,924.7 million at Dec 31, 2025).

28-04-2026

BeOne Medicines Ltd. achieved GAAP profitability for the first time in FY2025, generated meaningful cash flow through strong topline revenue growth, and reported BRUKINSA global revenues of $3.9B, up 49% YoY, while treating over 2 million patients with its medicines. The company employs nearly 12,000 colleagues and continues advancing its CLL pipeline with sonrotoclax (first approval in late 2025) and BGB-16673. This proxy statement for the June 11, 2026 Annual General Meeting seeks approval of FY2025 financial statements, appropriation of accumulated loss, discharge of liability, and re-election/election of board directors including John V. Oyler as Chairman.

• ·Annual General Meeting: June 11, 2026 at 3:30 p.m. local time, Prime Tower, Hardstrasse 201, CH-8005 Zürich, Switzerland.
• ·Record date: 12:00 p.m. CET on May 22, 2026.
• ·BRUKINSA approved in more than 75 markets; superior PFS vs. ibrutinib in Phase 3 ALPINE study.
• ·Sonrotoclax: U.S. FDA NDA action expected H1 2026 for relapsed/refractory mantle cell lymphoma.
• ·BGB-16673: Potential accelerated approval in 2027; three Phase 3 studies underway.
• ·Trading symbols: Nasdaq (ONC), HKEx (06160), SSE (688235).

28-04-2026

Rare Earths Americas, Inc., a Texas-incorporated exploration-stage company with no revenue generated to date, filed Amendment No. 1 to its S-1 registration statement on April 28, 2026, for an initial public offering of 2,777,777 shares of common stock at an estimated price of $17.00 to $19.00 per share, with an underwriter option for up to 416,666 additional shares, intending to list on NYSE American under the symbol 'REA'. The company advances rare earth projects including the Shiloh Project (1,927 acres in Georgia, US) with high-grade assays up to 30.98% TREO, Alpha Project (Brazil, 201.7 Mt inferred resource at 1,520 ppm TREO), and Constellation Project (Brazil, 266.2 Mt inferred resource at 2,637 ppm TREO), positioning for heavy rare earth supply. However, all projects remain in early exploration with only inferred resources disclosed, no mineral reserves established, and significant risks highlighted in the prospectus.

• ·Shiloh Project located on private land with established infrastructure and streamlined permitting pathway.
• ·Alpha and Constellation Projects feature shallow, laterally extensive IAC mineralization.
• ·Active drilling campaign started at Homer Project in Q1 2026.
• ·Company classified as emerging growth company and smaller reporting company.
• ·No mineral resources or reserves established at Shiloh Project.

28-04-2026

Coronado Global Resources Inc. reported Q1 March 2026 results with ROM production declining 21.7% QoQ to 5.4 Mt from 6.9 Mt and saleable production down 30.7% QoQ to 3.0 Mt, reflecting planned maintenance, CHPP shutdown at Curragh, longwall moves at Buchanan, weather delays, and Logan idling due to weak High-Vol market. Sales volumes fell 23.2% QoQ to 3.5 Mt, but realised met coal pricing rose 11.2% QoQ to US$165.4/t and overall group pricing increased 9.1% to US$133.2/t; Buchanan doubled EBITDA to US$30M despite challenges, and US$26M was received under revised Stanwell arrangements. Average mining cash costs surged 40.6% QoQ to US$135.3/t due to lower volumes, though expected to improve with higher run-rates.

• ·Logan Complex idled following WARN Act notice due to constrained High-Vol market demand.
• ·Curragh Complex experienced temporary coal recovery constraints from rain after strong overburden removal.
• ·Export sales increased to 74.4% of total group volumes QoQ (+1.2%).
• ·PLV HCC FOB AUS Index averaged US$234.7/t in Mar Q26 (+17.3% QoQ).

28-04-2026

Ligand Pharmaceuticals announced a definitive agreement dated April 27, 2026, to acquire XOMA Royalty Corporation for $39 per share in cash plus a CVR tied to Janssen Biotech Tremfya litigation proceeds, expected to close in Q3 2026 and immediately accretive by $0.50 to adjusted core EPS in 2026 and $1.50 in 2027. The deal adds seven commercial royalties (Vabysmo, Ojemda, Miplyffa as key drivers) and over 100 development-stage programs, more than doubling Ligand's portfolio, prompting raised 2026 guidance to royalty revenue of $225-250 million (from $200-225 million), total revenue $270-310 million (from $245-285 million), and adjusted core EPS $8.50-9.50 (from $8-9). No declines or flat metrics were reported, positioning Ligand for compounded growth.

• ·XOMA portfolio includes royalties, tax, and IP assets built since 2017 pivot, with nine acquisitions in last two years.
• ·Funding via cash on hand and credit facility, retaining capacity for $150-250M annual royalty asset investments.
• ·Additional catalysts: Ojemda Japan marketing decision, Miplyffa Europe marketing decision in 2026.
• ·Filspari FDA approval for FSGS (rare kidney disease) expands beyond IgAN; Ligand 9% royalty.

28-04-2026

Kimberly-Clark reported first quarter 2026 net sales of $4.2 billion, up 2.7% from prior year with organic sales growth of 2.5% driven by 3.0% volume-plus-mix gains, though partially offset by 0.5% lower pricing and a 1.8% divestiture impact. Adjusted operating profit increased 3.7% to $732 million, supported by productivity savings and lower expenses, while adjusted EPS attributable to Kimberly-Clark rose 2.1% to $1.97; however, adjusted gross margin declined 60 basis points to 37.9%, adjusted EPS from continuing operations fell 1.2% to $1.60, and North America net sales decreased 0.6%. International Personal Care net sales grew strongly 9.1% to $1.5 billion with 4.0% organic growth.

• ·Cash provided by operations was $745 million, up from $327 million prior year.
• ·Total debt decreased to $7.1 billion from $7.2 billion at year-end 2025.
• ·Reaffirmed 2026 outlook includes mid-to-high single-digit adjusted operating profit growth and double-digit adjusted EPS from continuing operations growth on constant-currency basis.
• ·Effective tax rate 23.9% reported (26.2% adjusted) vs 23.5% (20.7% adjusted) prior year.

28-04-2026

Herc Holdings reported Q1 2026 total revenues of $1,139 million, up 32% YoY from $861 million, driven by 33% growth in equipment rental revenue to $981 million following the H&E acquisition; Adjusted EBITDA rose 33% to $448 million with margin flat at 39%. However, the company posted a net loss of $24 million ($0.72 per share), wider than the prior year's $18 million loss, amid higher depreciation, interest expense up to $128 million from $62 million, and dollar utilization declining to 36.4% from 37.6%. Free cash flow nearly doubled to $94 million, and full-year 2026 guidance was affirmed.

• ·Average fleet at OEC increased 36% YoY in Q1 2026.
• ·Net leverage increased to 3.96x from 2.53x YoY.
• ·Liquidity of approximately $1.9 billion as of March 31, 2026.
• ·Quarterly dividend of $0.70 per share declared and paid.
• ·2026 gross capex guidance: $800 million to $1.1 billion.

28-04-2026

Hycroft Mining Holding Corporation announced Q1 2026 results with a strong balance sheet showing US$189.0 million in cash and cash equivalents and no debt, alongside a 55% increase in measured and indicated gold and silver mineral resources to 16.4 million ounces of gold and 562.6 million ounces of silver. The company maintained an exemplary safety record with 0.00 TRIFR and over 1.4 million work hours without lost-time incidents, while advancing its 2025-2026 Exploration Drill Program with more than 9,000 meters drilled and exceptional results at Vortex and Brimstone. It was added to the VanEck Junior Gold Miners ETF on March 20, 2026, and promoted to the MSCI Small Cap Index effective February 27, 2026.

• ·Filed Form 10-Q for period ended March 31, 2026 on April 28, 2026.
• ·Plans for 2026 include adding two core drill rigs (total four), step-out drilling for new targets, completing PEA for milling sulfide ore via pressure oxidation, trade-off analysis for pressure oxidation vs roasting, in-fill RC drilling and metallurgical test work for heap leach restart, and advancing future development activities.

28-04-2026

Rithm Capital Corp. reported Q1 2026 GAAP net income of $67.8 million ($0.12 per diluted common share), up 28% QoQ from $53.1 million ($0.09 per share), while non-GAAP Earnings Available for Distribution fell 31% QoQ to $289.6 million ($0.51 per share) from $418.9 million ($0.74 per share), with common dividend steady at $0.25 per share ($139.6 million). Newrez delivered pre-tax operating income of $273.7 million (19% annualized ROE) and origination volume of $15.5 billion (up 31% YoY but down 18% QoQ), Genesis origination grew 80% YoY to $1.6 billion, and asset management AUM reached $59 billion, up from $35 billion in Q1 2025. Servicing UPB hit $850 billion amid mixed segment performances including MSR MTM losses.

• ·Completed four non-qualified mortgage securitizations totaling $2.0 billion UPB in Q1 2026.
• ·Acquired $140 million in home improvement loans under forward flow with Upgrade, Inc., total purchased to date $667 million.
• ·Sculptor Capital committed over $1 billion to Real Estate Fund V and deployed over $2 billion in investments; issued new U.S. CLO for $400 million AUM.
• ·Crestline raised $100 million net inflows for Crestline Lending Solutions Fund, total commitments over $500 million.
• ·Elecor (rebranded from Paramount Group) saw 74% of new lease activity in San Francisco portfolio.
• ·Book value per common share of $12.51 as of March 31, 2026.

28-04-2026

Pentair plc reported strong Q1 2026 results with net sales of $1,037 million, up 3% YoY, GAAP EPS of $0.98 (up 5%), and adjusted EPS of $1.22 (up 10%), driven by operating income of $210 million (up 3%) and ROS expansion to 20.3%. While the Flow segment saw sales up 11% and reportable segment income up 22%, Water Solutions sales declined 1% and Pool sales grew only 1%, with core sales across segments up just 1-2%; net cash used for operating activities worsened to $67 million from $39 million YoY. The company repurchased $200 million in shares, raised FY2026 adjusted EPS guidance to $5.30-$5.40 (up 8-10% YoY), and introduced Q2 adjusted EPS guidance of $1.47-$1.50 (up 6-8%).

• ·50th consecutive year of dividend increases; Q1 dividend $0.27 per share (up from $0.25).
• ·Effective Jan 1, 2026, segment reorganization moved legacy residential and irrigation flow business from Flow to Water Solutions; prior periods reclassified.
• ·Q2 2026 sales guidance up ~1% YoY reported.
• ·Cash and equivalents $67.7M at Mar 31, 2026 (down from $101.6M at Dec 31, 2025); long-term debt $1,944.3M (up from $1,638.6M).

28-04-2026

AvalonBay Communities reported Q1 2026 EPS of $2.33, up 40.4% YoY from $1.66, primarily due to real estate gains, while FFO per share declined 2.2% to $2.72 and Core FFO per share remained flat at $2.83 versus prior year. Same Store Residential revenue increased 1.6% to $703,976,000, but operating expenses rose 4.7% to $224,039,000, limiting NOI growth to 0.2% at $479,937,000. The company completed one development (Avalon Lake Norman for $102,000,000), started two more totaling $188,000,000 estimated cost, sold three communities for $340,750,000, repurchased $198,480,000 in stock, and issued Q2 2026 guidance while reaffirming full-year Core FFO outlook but lowering EPS expectations.

• ·25 wholly-owned development communities under construction with 8,673 apartment homes and 69,000 square feet of commercial space for estimated $3,390,000,000 total capital cost.
• ·Received $17,580,000 repayment on one SIP mezzanine loan; new $15,000,000 commitment in April 2026, both for Metro NY/NJ multifamily projects.
• ·Annualized Net Debt-to-Core EBITDAre of 4.8 times; Unencumbered NOI of 95% for Q1 2026.
• ·$914,354,000 remaining capacity under 2026 Stock Repurchase Program.
• ·Q2 2026 guidance: EPS $1.23-$1.33, FFO per share $2.68-$2.78, Core FFO per share $2.72-$2.82; full-year Core FFO reaffirmed, EPS outlook $5.92-$6.42.
• ·Conference call on April 28, 2026 at 1:00 PM ET.

28-04-2026

CECO Environmental reported Q1 2026 results showing robust top-line growth with orders up 97% YoY to $449.5 million and backlog hitting a record $1,035.1 million (up 72%), alongside revenue growth of 17% to $205.9 million and adjusted EBITDA up 46% to $20.4 million. However, the company recorded a net loss of $(0.4) million (down 101% from prior profit), operating income down 97% to $1.9 million, and free cash flow of $(15.7) million (down 4%). CECO raised FY2026 guidance to revenue of $940-$1,000 million (up ~25% at midpoint) and adjusted EBITDA of $120-$140 million (up ~45%), while providing an update on its pending merger with Thermon expected to close in June 2026.

• ·Book-to-bill ratio of 2.2 in Q1 2026.
• ·Largest ever Natural Gas Power order booked in April 2026.
• ·Thermon stockholder vote expected May 27, 2026; merger close expected June 2026.
• ·Expected $40 million in cost synergies from Thermon merger.
• ·Gross margin of 31.0% in Q1 2026; expected to improve in H2 2026 due to higher margin backlog.
• ·Conference call scheduled for April 28, 2026 at 8:30 a.m. ET.

28-04-2026

Corning reported strong Q1 2026 core sales of $4.35 billion, up 18% YoY, and core EPS of $0.70, up 30% YoY, driven by robust demand for Gen AI products with Optical Communications sales up 36% YoY and Solar sales up 80% YoY. However, Solar net income declined 74% YoY to $7 million, Glass Innovations sales grew only 1% YoY, Automotive sales were down 1% YoY and flat QoQ, and overall sales declined 2% QoQ from Q4 2025. Q2 guidance projects core sales growth of about 14% YoY to approximately $4.6 billion and core EPS growth of about 25% YoY to $0.73-$0.77, incorporating a $30 million additional expense from an extended solar wafer facility maintenance shutdown.

• ·Two additional hyperscale customers entered large, long-term agreements similar in size and duration to the up-to-$6 billion Meta deal.
• ·Springboard plan to be upgraded and extended through 2030, announced at May 6 NYC investor event.
• ·GAAP gross margin 36.9%; core gross margin 39.1% (expanded 120 basis points YoY).
• ·Core operating margin 20.2% (expanded 220 basis points YoY); GAAP operating margin 15.4%.
• ·Investor event at NYSE on May 6, 2026, starting 9 a.m. ET.

28-04-2026

JetBlue reported first quarter 2026 operating revenue of $2,240 million, up 4.7% year-over-year, with RASM increasing 6.5% driven by resilient demand and strong Fort Lauderdale performance including 5% RASM growth on 23% capacity increase. However, system capacity decreased 1.7% YoY, CASM rose 8.3%, CASM ex-Fuel increased 6.6%, and average fuel price rose 15.2% to $2.96 per gallon, resulting in an operating loss of $224 million (worsened 28.5% YoY) and operating margin of -10.0%. The company bolstered liquidity to $2.4 billion, executed $500 million in aircraft-backed financing, and announced capacity reductions and cost controls to address elevated fuel costs.

• ·Fort Lauderdale capacity growth of 23% YoY in Q1 2026.
• ·Loyalty cash remuneration grew 19% YoY, with 45% increase in card acquisitions.
• ·Q2 2026 capacity guidance: +1.5% to +4.5% YoY ASMs; RASM +7.0% to +11.0%; CASM ex-Fuel +3.0% to +5.0%; fuel $4.13-$4.28/gallon.
• ·Full year 2026 capex guidance ~$800 million.
• ·On track for $310 million incremental EBIT from JetForward in 2026.

28-04-2026

Sensei Biotherapeutics, Inc. (SNSE) filed an S-3 shelf registration statement on April 28, 2026, following its completion of the acquisition of Faeth Therapeutics on February 17, 2026, which added the lead asset PIKTOR (serabelisib + sapanisertib) targeting the PI3K/AKT/mTOR pathway for endometrial and breast cancers to its pipeline. Concurrently, the company raised approximately $200 million in gross proceeds through a PIPE financing on February 20, 2026, issuing 14,440.395 shares of Series B Preferred Stock convertible to 14,440,395 common shares. PIKTOR's Phase 2 trial in endometrial cancer anticipates topline data by year-end 2026, with a Phase 1b breast cancer trial planned for H1 2026; legacy programs like solnerstotug have only 7 patients remaining as of March 23, 2026.

• ·Acquisition treated as asset acquisition under ASC 805 due to >90% fair value in PIKTOR.
• ·Series B Preferred Stock: non-voting, convertible 1:1000 to common, issued 10,497.098 shares for acquisition and 14,440.395 for PIPE.
• ·Nasdaq listing application filed; potential name change to Faeth Therapeutics, Inc. (FTH).
• ·180-day lock-up agreements for certain officers, directors, and stockholders.
• ·Resale registration statement obligated within 75 days of PIPE closing.
• ·Emerging growth company status until annual revenues exceed $1.235 billion.

28-04-2026

HUHUTECH International Group Inc.'s 20-F annual report discloses key risks including PRC regulatory restrictions on dividend payments from subsidiaries, requiring a minimum 10% of net income to be set aside as statutory surplus reserves until reaching 50% of registered capital, and a potential 10% withholding tax on dividends to non-PRC entities. Additional risks encompass reliance on subsidiary dividends for cash needs, unfavorable tax consequences if classified as a PRC resident enterprise, currency fluctuations in RMB and JPY impacting USD-quoted shares, challenges in maintaining Nasdaq Capital Market listing, extreme stock price volatility, no expectation of paying dividends, and limitations as a Cayman Islands-incorporated foreign private issuer and emerging growth company.

• ·PRC subsidiaries must reserve at least 10% of after-tax net income annually until reserves equal 50% of registered capital.
• ·Business primarily conducted in RMB and JPY, with Ordinary Shares quoted in USD.
• ·Company is a Cayman Islands-incorporated foreign private issuer and emerging growth company, exempt from certain U.S. domestic company rules.
• ·Potential classification as PRC resident enterprise for tax purposes.
• ·No expectation to pay dividends in the foreseeable future.

28-04-2026

Biomea Fusion reported positive 52-week topline results from its Phase 2 COVALENT-112 trial of icovamenib in type 1 diabetes, with a 52% increase in mean C-peptide AUC at Week 12 (p<0.001; n=5) in patients diagnosed 0-3 years ago, though levels showed a 7% decline from baseline at Week 52; longer-standing patients (3-15 years) had C-peptide levels generally preserved with a modest decline. The drug was well-tolerated with a dose response favoring 200 mg, and effects persisted post-treatment, outperforming published natural history declines. A new Phase 2 trial with extended dosing is planned for H2 2026 across four U.S. centers, following an FDA hold that limited enrollment to half the intended population.

• ·Study enrollment interrupted by FDA clinical hold in May 2024, resulting in approximately half the intended patient population and no placebo-controlled Part 2.
• ·Cohort 1 (0-3 years diagnosis): screening C-peptide ≥0.2 nmol/L; Cohort 2 (3-15 years): ≥0.08 nmol/L.
• ·Comprehensive dataset to be presented at American Diabetes Association Scientific Sessions in June 2026.
• ·Icovamenib: 100 mg or 200 mg once daily for 12 weeks + 40-week follow-up.

28-04-2026

Maravai LifeSciences Holdings, Inc. (MRVI) filed a DEFA14A proxy statement detailing its board structure, reduced from 11 to 8 directors since the 2025 annual meeting, with Class III directors (Bernd Brust, Gregory T. Lucier, Luke Marker) up for election to serve until 2029. The filing outlines deadlines for 2027 Annual Meeting shareholder proposals (December 25, 2026 for Rule 14a-8 inclusion) and nominations (by close of business February 25, 2027). It also describes the Director Nomination Agreement providing GTCR entities with board nomination rights scaled to ownership levels (e.g., 100% if >=40% of IPO ownership).

• ·Shareholder proposals under Rule 14a-8 for 2027 AGM inclusion must be received no later than December 25, 2026.
• ·Director nomination notices (not for proxy inclusion) due by close of business February 25, 2027 (not earlier than January 26, 2027).
• ·Universal proxy rule notice for competing nominees due by March 27, 2027.
• ·Ratification of Deloitte & Touche LLP as auditor for year ending December 31, 2026 is a routine matter allowing broker discretionary voting.
• ·Ages of directors as of March 27, 2026: Bernd Brust (59), Gregory T. Lucier (61), Luke Marker (41), Susannah Gray (65), R. Andrew Eckert (64), Constantine Mihas (59), Sean Cunningham (50), John DeFord (64).

28-04-2026

Polaris Inc. reported Q1 2026 sales of $1,659 million, up 8% YoY from $1,536 million, with North America sales up 10% to $1,426 million while international sales declined 5% to $233 million; gross profit margin expanded 423 bps to 20.2%. Operating expenses rose 29% to $390 million, leading to a reported net loss of $47.4 million (improved from $66.8 million YoY) and adjusted EPS of $0.13; segment sales grew in Powersports (+14%), Marine (+9%), and Aixam & Goupil (+9%), but Corporate sales fell sharply due to the Indian Motorcycle divestiture. Total retail sales rose 1% YoY (ORV +3%), and full-year 2026 adjusted sales guidance of $7.15-7.30 billion and EPS of $1.60-1.70 was reaffirmed.

• ·Adjusted gross profit margin increased 389 bps to 20.5%.
• ·Q1 2026 diluted EPS reported $(0.83) vs $(1.17) prior year; adjusted $0.13.
• ·Adjusted EBITDA margin 6.2% (+277 bps YoY).
• ·PG&A sales in Powersports up 14%; in Aixam & Goupil up 18%.
• ·Cash and cash equivalents $282.0 million at March 31, 2026 (down from $291.7 million prior year).
• ·Total assets $5,241.5 million at March 31, 2026 (down from $5,450.4 million).

28-04-2026

This DEF 14A proxy statement discloses beneficial ownership of Lindblad Expeditions Holdings, Inc. common stock as of April 14, 2026, with 65,499,714 shares outstanding; insiders (16 directors and executives) collectively own 17,079,026 shares (26.1%), led by Sven-Olof Lindblad at 10,675,063 shares (16.3%), while 5% owners include Ariel Investments, LLC (5,524,660 shares, 8.4%) and Capitol Acquisition Management 2 LLC (3,324,820 shares, 5.1%). Stockholders are voting to elect four Class B directors (L. Dyson Dryden, John M. Fahey, Catherine B. Reynolds, Andy Stuart) for terms until the 2029 annual meeting. Two late Section 16(a) filings were noted: one by Sven Lindblad and one by Benjamin Bressler.

• ·Board is staggered into three classes with 11 directors: Class A (4), Class B (4, up for election), Class C (3).
• ·Two delinquent Section 16(a) reports in 2025: Sven Lindblad (April 2, forfeiture of unearned RSUs), Benjamin Bressler (April 15, withholding for taxes on vesting).
• ·Annual meeting voting results to be announced preliminarily at meeting and finalized in Form 8-K within four business days.

28-04-2026

Christian Angermayer, Chairman of Enhanced Ltd., posted on X promoting the imminent merger with SPAC A Paradise Acquisition Corp. (APAD), highlighting key deadlines: April 29, 2026, for investors to buy shares and elect non-redemption at $10 per share valuation; May 1, 2026, shareholder vote; May 7, 2026, expected closing; and May 8, 2026, trading as ENHA on NYSE. The combined entity will be Enhanced Group Inc., an elite sports and consumer products company focused on Enhanced Games and telehealth. While optimistic about future growth, the filing discloses significant risks including Enhanced's unproven business model, minimal revenue history, regulatory scrutiny, and high redemption risks.

• ·APAD shares trade on Nasdaq until closing, then ENHA on NYSE
• ·Merger proxy and S-4 registration statement available on SEC EDGAR
• ·Contact for documents: The Sun’s Group Center, 29th Floor, 200 Gloucester Road, Wan Chai, Hong Kong, +852 9583 3199

28-04-2026

Enterprise Products Partners L.P. reported robust Q1 2026 earnings with operating income of $1.9 billion (up 8% YoY), net income attributable to common unitholders of $1.5 billion (up 6%), Adjusted EBITDA of $2.7 billion (up 10%), and record volumes including natural gas processing inlet at 8.3 Bcf/d (up 7%), equivalent pipeline transportation at 14.2 MMBPD (up 7%), and NGL fractionation at 1.9 MMBPD (up 16%). However, Crude Oil Pipelines & Services gross operating margin declined to $329 million from $374 million YoY, Petrochemical & Refined Products Services remained flat at $314 million versus $315 million, and certain sub-segments like LPG-related activities at EHT dropped $42 million. Distributions rose 2.8% to $0.55 per common unit, backed by Operational DCF of $2.1 billion (up 5%) providing 1.8x coverage.

• ·Growth capital spending for 2026 expected $2.3 to $2.6 billion net of $596 million asset sale proceeds; sustaining capex $580 million.
• ·12 new operational records set in Q1 2026.
• ·Approximately $5.3 billion of major growth capital projects under construction.
• ·Permian natural gas processing capacity growing at 17% CAGR since Navitas Midstream acquisition in 2022.

28-04-2026

RE/MAX Holdings, Inc. entered into an Arrangement Agreement and Plan of Merger dated April 26, 2026, with The Real Brokerage Inc. (Parent), Rome Wildlife, Inc. (New Wildlife), and affiliates, outlining a strategic combination involving the prior Rhino Merger, a 10-for-1 share consolidation of Parent Common Shares, an Exchange under the Plan of Arrangement, and two-step mergers resulting in RE/MAX becoming a wholly-owned subsidiary of New Wildlife. The respective boards have unanimously approved the transaction (subject to certain conditions), obtained fairness opinions, and secured voting and support agreements from key stockholders and shareholders. The structure is intended to qualify as a tax-free reorganization under Sections 368(a) and 351 of the Code.

• ·Voting and Support Agreements executed concurrently by certain Company stockholders (Exhibit C) and Parent shareholders (Exhibit D).
• ·TRA Termination Agreement with Rhino (Exhibit H) to terminate the Tax Receivable Agreement dated October 7, 2013, conditioned on Closing.
• ·Transactions interdependent: Rhino Merger immediately prior to Arrangement Effective Time; Mergers following on same Closing Date.

28-04-2026

The SPAC Board unanimously approved the Business Combination Agreement to merge with a target company forming Pubco, a publicly traded XRP treasury vehicle, citing attractive market opportunity, over $1 billion in equity commitments at $10.00 per share, initial XRP holdings of at least 473,276,430 XRP, and a fairness opinion from CCM. Pubco aims to grow via ecosystem participation, yield generation, and NAV-accretive structure, led by experienced executives like Asheesh Birla (CEO). However, risks include SPAC shareholders holding a minority position post-merger, potential high redemptions reducing trust cash below $5,000,001, and uncertainty that projected benefits will be achieved.

• ·Transactions structured as 'Up-C' with Pubco as public corporation and operating company as partnership for tax purposes, allowing in-kind XRP contributions.
• ·Six-month lockup on Pubco Class A and Class C Common Stock for certain Ripple affiliates, Sponsor, and SPAC Insiders.
• ·SPAC financial advisor CCM provided fairness opinion on the Exchange Ratio.

28-04-2026

Ares Capital Corp's total investment income rose 4% YoY to $763M for the three months ended March 31, 2026, driven by increases across non-controlled/non-affiliate ($614M, +3% YoY) and controlled affiliate investments ($142M, +15% YoY), with net investment income up 9% YoY to $398M. However, net unrealized losses widened significantly to $412M from $63M YoY, leading to a net increase in stockholders' equity from operations of $92M (down 62% YoY from $241M) and QoQ declines in total assets to $30,679M (-2% from $31,235M), stockholders' equity to $14,065M (-2% from $14,318M), and NAV per share to $19.59 (-2% from $19.94). Debt decreased slightly QoQ to $15,848M from $15,991M.

• ·Net realized gains of $106M for Q1 2026, improved from net realized losses of $61M YoY.
• ·Foreign currency forward contracts show total unrealized appreciation of $11M as of March 31, 2026.
• ·Interest rate swaps have total fair value of $36M as of March 31, 2026.
• ·Portfolio includes first lien senior secured loans to software and SaaS providers like Auctane ($143.4M principal) and Banyan Software ($260.0M total fair value).

28-04-2026

Rising Stella Capital Pte. Ltd, a Singapore-based investment manager, filed its Form 13F-HR on April 28, 2026, disclosing equity holdings as of March 31, 2026, with a total market value of $213601262. The portfolio is concentrated in three ETFs: SPDR S&P 500 ETF Trust valued at $92658492 (142477 shares), Invesco QQQ Trust Series 1 at $91139031 (157904 shares), and iShares Bitcoin Trust ETF at $29803739 (775735 shares), all held with sole voting authority.

• ·All positions held with sole voting and disposition authority (SH SOLE).
• ·Filer's address: 9 Raffles Place #59-01 Republic Plaza, Singapore 048619.
• ·SEC file number: 028-26717.

28-04-2026

Farnam Financial LLC, an Arizona-based investment manager, filed its 13F-HR on April 28, 2026, disclosing $121,517,718 in total holdings across 49 positions as of March 31, 2026. The portfolio is dominated by ETFs, with top holdings including Vanguard Total Stock Market ETF ($11,626,314, 36,240 shares), iShares 0-3 Month Treasury ($10,631,707, 105,620 shares), and Schwab U.S. Large-Cap ETF ($9,355,838, 364,892 shares). Individual stocks such as Apple ($4,848,165, 19,103 shares), Intel ($2,887,291, 65,427 shares), and Berkshire Hathaway ($2,846,927, 5,941 shares) represent smaller allocations.

• ·All positions reported with sole discretionary voting power (OTR 0 0).
• ·Business address: 4539 N 22nd St Ste N, Phoenix, AZ 85016.
• ·SEC file number: 028-25707.

28-04-2026

Topor & Co. Korea filed its quarterly 13F-HR report disclosing $118,249,710 in total holdings across 18 positions as of March 31, 2026. The portfolio is diversified across equity and fixed income ETFs, with top holdings including Vanguard Intl Equity Index F TT WRLD ST ETF ($31,251,053), Vanguard Index Fds S&P 500 ETF ($24,986,553), and iShares TR MSCI ACWI ETF ($18,256,123). No prior period comparisons are available in this filing.

• ·Filing covers period ending March 31, 2026, filed on April 28, 2026
• ·All holdings reported as sole discretionary with zero shared or other voting authority

28-04-2026

Security National Financial Corporation (SNFCA) filed a DEFA14A Definitive Additional Proxy Materials on April 28, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee is required and is submitted by the registrant. No substantive proxy details or financial data are provided in the document.

• ·Filing Type: DEFA14A
• ·Subcategory: Proxy Statement
• ·Filed by Registrant (checked)
• ·No fee required

28-04-2026

Nautilus Biotechnology reported Q1 2026 operating expenses of $16.1 million, down 14% YoY from $18.8 million, driven by lower R&D and SG&A costs, narrowing net loss to $14.7 million from $16.6 million. Business highlights include launching the Iterative Mapping Early Access Program with Baylor College of Medicine as the first customer and appointing Amber Faust as VP Global Sales. However, the company remains pre-revenue with ongoing cash burn of $13.1 million in operating activities, and total cash, equivalents, and investments declined to $143.4 million as of March 31, 2026.

• ·Total assets decreased to $177.8 million as of March 31, 2026 from $191.1 million as of December 31, 2025.
• ·Net cash provided by investing activities was $14.2 million in Q1 2026.
• ·Conference call scheduled for April 28, 2026 at 5:30 AM PT / 8:30 AM ET.

28-04-2026

ASA Gold & Precious Metals Limited is in the process of selling a portion of its position in a privately held portfolio company through multiple transactions at different prices, with each transaction recognized upon closing. If consummated at anticipated prices, this could result in an approximate 2-3% increase in net asset value. However, there is no assurance that any transactions will complete or at the expected prices.

• ·Filing discloses information under Item 7.01, furnished not filed, not subject to Section 18 liability or incorporation by reference.
• ·Common Shares trade as ASA on NYSE, par value $1.00 per share.

28-04-2026

Innovative Digital Investors Acquisition Corp., a blank check company focused on financial services targets in North America, has filed Amendment No. 5 to its S-1 registration statement for an IPO of 20,000,000 units priced at $10.00 each, consisting of one share of common stock and one-half of one redeemable warrant exercisable at $11.50. The sponsor commits to purchasing 275,000 private units at $10.00 and 1,000,000 Sponsor OTM warrants at $0.10 each (exercisable at $15.00), for total consideration of $2,850,000, while initial stockholders hold 7,475,000 founder shares purchased for approximately $43,333. The company has 24 months to complete an initial business combination, with standard SPAC risks including potential high redemptions leading to significant dilution (e.g., NTBV as low as $0.15 at maximum redemption).

• ·Underwriters have a 45-day option to purchase up to 3,000,000 additional units for over-allotments.
• ·Warrants become exercisable on the later of 30 days after initial business combination or 12 months from IPO closing, expiring 5 years post-combination (10 years for Sponsor OTM Warrants).
• ·Pro forma NTBV per share ranges from $7.48 (no redemption) to $0.15 (maximum redemption assuming full over-allotment).
• ·Public stockholders can redeem up to 15% of shares upon business combination at trust account value per share.
• ·Company is an emerging growth company under federal securities laws.
• ·Nasdaq listing applied for: units IDIAU, common stock IDIA, warrants IDIAW.
• ·Sponsor reimbursed $15,000 per month for office space and services.

28-04-2026

Novus Advisors, LLC filed a 13F-HR report disclosing 47 equity holdings totaling $44,702,426 as of March 31, 2026, with 0 changes reported since the prior filing. The portfolio is dominated by ETFs from iShares and SPDR series, including top positions in State Street SPDR S&P 500 ETF Trust ($4,670,748), SPDR S&P 500 ETF ($3,953,275), and SSGA Active Trust State Street US ($3,343,126). Individual stocks such as Exxon Mobil Corp ($709,857), Union Pacific Corp ($597,816), and Amazon.com Inc ($281,164) represent smaller allocations.

28-04-2026

Controladora Vuela Compania de Aviacion, S.A.B. de C.V. (Volaris) discloses 100% equity ownership in five Mexican trusts (Banco Multiva Fidecomisos CIB/3853, 3855, 3866, 3867, 3921) for financing pre-delivery payments under its Airbus aircraft purchase agreement, with Banco Multiva assuming rights from CIBanco effective September 2, 2025. The company also reports 100% ownership in Fidecomiso CIB/3249, through which subsidiary Volaris Opco issued three series of asset-backed securities notes (15 million units each): VOLARCB 19 (Ps.1.5B or $78.5M, fully amortized June 20, 2024), VOLARCB 21L (Ps.1.5B or $72.1M), and VOLARCB 23 (Ps.1.5B or $85.8M), under CNBV-approved programs up to Ps.3.0B ($157.1M/$144.2M) and Ps.5.0B ($286.2M). Two additional 100%-owned administrative trusts (F/745291 and CIB/3081) manage shares.

• ·VOLARCB 19 notes fully amortized on June 20, 2024.
• ·Banco Multiva assumed all rights and obligations of CIBanco effective September 2, 2025.

28-04-2026

Centene Corporation reported strong Q1 2026 financial results with premium and service revenues up 5% YoY to $44,655 million, adjusted diluted EPS of $3.37 exceeding expectations by $0.50, HBR improving to 87.3% from 87.5%, and SG&A ratio declining to 7.6% from 7.9%, alongside $1.0 billion debt reduction and $4,366 million operating cash flow. However, total at-risk membership fell 6% YoY to 26,272,900, driven by sharp Commercial declines (Marketplace down 36% to 3,582,200) and Medicaid reductions to 12,426,900. The company raised FY2026 adjusted diluted EPS guidance to greater than $3.40 and premium revenues to $171.0-$175.0 billion.

• ·Centene named one of the World's Most Admired Companies by Fortune for eighth consecutive year.
• ·FY2026 guidance: Total revenues $187.5-$191.5 billion; HBR 90.9%-91.7%; Adjusted SG&A 7.0%-7.6%.
• ·Conference call scheduled for April 28, 2026 at 8:30 a.m. ET.
• ·Days in claims payable (DCP) at 48 days, up 2 days from Q4 2025.

28-04-2026

News Corporation filed an 8-K disclosing information provided to the Australian Securities Exchange (ASX) regarding its ongoing stock repurchase program, which authorizes up to $1 billion in aggregate for Class A and Class B common stock. The disclosures are attached as Exhibits 99.1 and 99.2, with forward-looking statements on intent to repurchase shares from time to time, subject to market conditions and other factors.

• ·Filing pertains to Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits).
• ·Class A Common Stock (NWSA) and Class B Common Stock (NWS) traded on Nasdaq Global Select Market.
• ·Date of earliest event reported: April 27, 2026; Filing Date: April 28, 2026.

28-04-2026

Aquaron Acquisition Corp., a blank check company, is holding a special stockholder meeting on May 7, 2026, to vote on amending its charter and trust agreement to extend the business combination deadline monthly up to 12 times from May 6, 2026, to May 6, 2027, funded by sponsor contributions of $0.033 per public share per month (up to $194,376.6 total if fully extended). This extension is needed to complete the proposed merger with HUTURE Ltd. after terminating a prior agreement with Bestpath on July 12, 2024; without approval, the company will liquidate and redeem public shares at approximately $1.48 each. The board unanimously recommends approval, noting public stockholders retain redemption rights now or later.

• ·Record date for voting: April 23, 2026
• ·Special meeting: May 7, 2026 at 11:00 a.m. ET, virtual at www.cleartrustonline.com/aqu
• ·Merger Agreement signed: July 12, 2024
• ·Prior Bestpath Merger Agreement terminated: July 12, 2024
• ·Trust Agreement originally dated: October 3, 2022, amended June 29, 2023, April 30, 2024, May 6, 2025

28-04-2026

Cooper Investors PTY LTD filed its 13F-HR report for the quarter ended March 31, 2026, disclosing holdings in 42 equity positions with a total market value of $245328286. The portfolio includes diversified positions across technology (e.g., Alphabet Inc. Class A at $4216780, Microsoft at $4468322), media (e.g., News Corporation Class A at $39412560), and other sectors, all held with sole voting power. No changes in holdings or voting authority were indicated in the filing.

• ·All 42 positions held with sole shared investment discretion and sole voting power (SH SOLE).
• ·Filing covers period ended 03-31-2026, submitted 04-28-2026.

28-04-2026

Corvex, Inc. (formerly associated with Movano Inc., ticker MOVE) filed Amendment No. 1 to its 10-K for the fiscal year ended December 31, 2025, on April 28, 2026, pursuant to General Instruction G(3) as it will not file a definitive proxy statement within 120 days of fiscal year-end. The amendment restates Part III items (Directors, Executive Compensation, Security Ownership, Related Transactions, and Accountant Fees), updates the cover page to note no incorporated documents, and adds new certifications, the 2024 Equity Incentive Plan, and a common stock description as exhibits. No financial statements or related disclosures were amended or included.

• ·Entity is a Non-accelerated Filer, Small Business, and Emerging Growth Company.
• ·Entity File Number: 001-40254; CIK: 0001734750; EIN: 82-4233771.
• ·Trading on NASDAQ under symbol MOVE.
• ·Address: 3401 North Fairfax Drive, Suite 3230, Arlington, VA 22226.
• ·Original 10-K filed March 31, 2026.

28-04-2026

Stewards, Inc. disclosed executive compensation for 2025 showing significant increases in total pay primarily due to $1,000,000 RSU grants to each named executive officer, with Vincent Napolitano's total rising 103% YoY to $1,913,432 and Shaun Quin's up 192% to $1,562,430; however, base salaries declined for some like Napolitano (from $233,610 to $205,432). The company approved a new executive compensation program with STI/LTI elements, stock ownership guidelines, and clawbacks, alongside a leadership transition where Vincent Napolitano steps to Chairman Emeritus, Glen Steward to Chairman, and Shaun Quin to CEO. Directors will receive $30,000 annual cash retainers plus $135,000 in RSUs under a new policy effective Q4 2025.

• ·Glen Steward resigned as Chief Strategy Officer effective Dec 1, 2025, but remains on Board.
• ·No compensation expense recognized for 2025 RSUs as vesting not probable at Dec 31, 2025.
• ·RSU vesting requires uplisting to Nasdaq, S-8 effectiveness, and service period.
• ·Incentive Plan effective Aug 21, 2024, terminates Aug 21, 2034 unless earlier.
• ·New comp program phased 2025-2028; ownership guidelines 6x salary for CEO, etc.
• ·Board majority-independent post-Napolitano transition per Nasdaq Rule 5605.

28-04-2026

Insight Inv LLC filed its 13F-HR on April 28, 2026, reporting total equity holdings valued at 182747722 USD as of March 31, 2026, across 104 positions all held with sole voting power. Top holdings include Apple Inc (8113666 USD, 31970 shares), First Trust Exchange Traded Fund Rising Dividend Achievers (5863818 USD, 85879 shares), and Corning Inc (5456748 USD, 40132 shares). No prior period comparisons or changes are provided in the filing.

• ·Filing CIK: 0001909322
• ·Business address: 330 Illinois Street, El Segundo, CA 90245
• ·Phone: 310-426-6322

28-04-2026

Baker Boyer National Bank filed its 13F-HR on April 28, 2026, disclosing total holdings of $332827952 across 119 positions as of March 31, 2026. The portfolio emphasizes ETFs, with the largest positions in DFA U.S. Core Equity 2 ETF ($63332590), DFA World Ex-U.S. Core Equity 2 ETF ($56925839), and Vanguard Muni Bond Tax Exempt ($56226828). Notable individual stock holdings include Microsoft Corp ($7074319), Apple Inc ($4349199 sole), and Paccar Inc ($4216443).

• ·Portfolio includes both sole discretionary (SH SOLE) and defined (SH DFND) holdings.
• ·Filer located in Walla Walla, WA; CIK 0001079398.
• ·No other managers reported (0 managers).

28-04-2026

Ryan Investment Management, Inc. filed a 13F-HR report on April 28, 2026, disclosing its equity holdings as of March 31, 2026, with a total portfolio value of $177829558 across 20 positions, primarily ETFs. Top holdings include iShares MSCI EAFE ETF at $36297870, ProShares Short QQQ ETF at $34302469, ProShares Short S&P500 ETF at $34034020, iShares Russell 1000 Value ETF at $24115865, and State Street SPDR Bloomberg 1-3 Month T-Bill ETF at $11541600. The portfolio features a mix of long equity ETFs, short ETFs, bond ETFs, and one individual stock position in Eli Lilly & Co. valued at $836071.

• ·Filing filed as of April 28, 2026, for period ended March 31, 2026.
• ·All positions reported with sole voting power.
• ·Business address: 22860 Two Rivers Road, Suite 200, Basalt, CO 81621.

28-04-2026

Oarsman Capital, Inc., based in Milwaukee, WI, filed its 13F-HR on April 28, 2026, disclosing holdings as of March 31, 2026, with a total portfolio value of $805532165 across 239 positions. Top holdings feature ETFs like Schwab International Equity ETF ($69462218, shares up 41%) and Vanguard Value ETF ($61660379, shares up 47%), alongside stocks such as Alphabet Inc. Class C ($18892204, shares +6.8% QoQ), NVIDIA Corporation ($12318401, shares +11.2% QoQ), and Microsoft Corp ($11362655, shares +6.6% QoQ). While many positions increased, others like Ulta Beauty Inc (690 shares, flat QoQ) and Invesco QQQ Trust Series I (1194 shares, flat QoQ) showed no change.

• ·New position: Rambus Inc. (3020 shares valued at $259811)
• ·Significant share increase: United Airlines Holdings Inc. (11150 shares added to 12749)
• ·Business address: 790 N. Water St., Ste 1850, Milwaukee, WI 53202